| 名稱 | hIL9 Effector Reporter Cell |
| 型號(hào) | CBP74207 |
| 報(bào)價(jià) | ![]() |
| 特點(diǎn) | hIL9 Effector Reporter Cell |
產(chǎn)品搜索
相關(guān)文章
- CD47/PD-(L)1 雙靶點(diǎn)細(xì)胞篩選模型簡(jiǎn)介
- 抑制性檢查點(diǎn)靶點(diǎn)及其細(xì)胞篩選模型
- 一起認(rèn)識(shí)下腫瘤細(xì)胞的遷移性
- 羅氏乳腺癌新藥獲英國(guó)NICE批準(zhǔn)用于HER2乳腺癌新輔助治療
- 關(guān)于sigma試劑的使用時(shí)長(zhǎng)相關(guān)說(shuō)明
- ATCC細(xì)胞的細(xì)胞破碎
- GABA細(xì)胞篩選模型
- CYP2C9基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- 腫瘤細(xì)胞能無(wú)限分裂的原因有哪些?
- CSF3R細(xì)胞篩選模型
聯(lián)系我們
聯(lián)系人:蔣經(jīng)理
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > 腫瘤免疫細(xì)胞株 > CBP74207hIL9 Effector Reporter Cell
- 詳細(xì)內(nèi)容
hIL9 Effector Reporter Cell
| I. Background | |
| IL9 (Interleukin 9) is a Protein Coding gene. Diseases associated with IL9 include Severe Combined Immunodeficiency, X-Linked and Trichuriasis. Among its related pathways are Apoptotic Pathways in Synovial Fibroblasts and MIF Mediated Glucocorticoid Regulation. | |
| II.Introduction | |
| Expressed gene: | IL9R |
| Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
| Freeze Medium: | 90% FBS+10%DMSO |
| Culture Medium: | DMEM+10%FBS+2μg/ml Puromycin+100μg/ml Hygromycin B+5μg/ml Blasticidin+400μg/ml G418 |
| Mycoplasma Testing: | Negative |
| Storage: | Liquid nitrogen |
| Application(s): | Functional(Report Gene) Assay |
| III. Representative Data | |
Figure 1. Recombinant hIL9 Effector Reporter Cell constitutively expressing CD132.
Figure 2. Recombinant hIL9 Effector Reporter Cell constitutively expressing IL9R. | |
Figure 3. Dose Response of Recombinant Human IL9 in hIL9 Effector Reporter Cells (C18) | |
Figure 4.Inhibition of Human IL9-induced Reporter Activity by hIL9 Neutralization Ab in hIL9 Effector Reporter Cells (C18). | |








會(huì)員_a.png)